Mouse macrophages can be primed by exposure in vitro to the bacterial products lipopolysaccharide and muramyl dipeptide (MDP) or in vivo by injection of MDP, so that they produce more of the bactericidal agent superoxide anion (O2) when stimulated by phagocytosis or by contact with phorbol myristate acetate (PMA).
postpartum) or from transitional milk (5 to 8 days). Release of O2 by milk macrophages was almost identical to that by blood monocytes from the same women. Milk macrophages phagocytized and killed Candida albicans relatively effectively. Incubation with lipopolysaccharide activated the macrophages in that they were primed for greater PMA-stimulated O2 release. Incubation with the adjuvant MDP or its analog 6-0-(2-tetradecylhexadecanoyl)-MDP did not prime, but incubation with a second analog, 6-0-(stearoyl)-MDP, primed the macrophage for greater O2 release. These results indicated that human tissue macrophages can be primed for greater oxidative response by exposure to bacterial products. Potential exists for the therapeutic use of such immunomodulating agents in the enhancement of host defense.
Animals that have been infected with intracellular microorganisms such as Listeria monocytogenes or Mycobacterium bovis develop activated macrophages characterized by larger size, enhanced spreading, and increased metabolic and functional activities, including increased ability to kill microorganisms (9, 23, 24) and tumor cells (25) . One of the principal biochemical phenomena underlying the enhanced killing potential of activated macrophages is their increased ability to generate toxic oxygen metabolites, including superoxide anion (02-), in response to phagocytosis or exposure to surface-active stimuli such as phorbol myristate acetate (PMA) (6, 15) . We have previously shown that enhanced O2 response can also be produced without active infection by injecting an animal with the chemically defined bacterial product muramyl dipeptide (MDP). Mice injected with MDP survive challenge infections that are lethal to control animals (4) .
Little is known about the physiology of human tissue macrophages or the process of macrophage activation in the human. We therefore examined the macrophages that are present in large numbers in human colostrum and milk. Although their role in the baby is largely unknown, these macrophages may be responsible, at least in part, for the protection afforded by breast milk against necrotizing enterocolitis (20) , and it is likely that they play an important role in protecting against breast infection. The current studies were undertaken to assess further the human milk macrophage as an infection-fighting cell and to explore the possibility that human milk macrophages might be activated with immunopotentiating pharmacologic agents. O2 release. Adherent cells were washed twice with HBSS and then assayed for production of 0-measured as superoxide dismutase-inhibitable reduction of ferricytochrome c (6, 7). The stimulus was PMA (0.5 ,ug/ml; Consolidated Midland Corp., Brewster, N.Y.). After removal of the O2-assay mixture, the cells were washed three times with HBSS, and protein was determined by the Lowry method (6) .
Phagocytosis of C. albicans. C. albicans (ATCC 18804) was used for assays of phagocytosis and phagocytic killing as previously described (4, 24) , using cells adherent to glass cover slips and ratios of 10 candidas to 1 cell. After incubation for 60 min at 37°C, cover slips were washed and then double-stained with Wright's and Giemsa stains. Approxi. mately 95% of cell-associated candidas could be seen within a detectable phagocytic vacuole (4).
Candidacidal assay. Mononuclear cells were plated on 16-mm-diameter dishes, washed, and then incubated with candidas in 0.5 ml of HBSS with 20% fresh fetal calf serum at 37°C in 5% C02-95% air (4, 24) . The number of candidas added was adjusted such that the macrophage:candida ratio was 3:1. The reaction was stopped by sonication for 30 s, and diluted suspensions were cultured in pour plates made with Sabouraud agar. The number of colonies formed was determined in plates from triplicate plating.
RESULTS
The release of O2-was compared with macrophages from milk obtained in the first 72 h postpartum (colostrum) and from milk obtained 5 to 8 days postpartum (transitional milk) (Fig. 1) . There was no significant difference in O2 production by macrophages from colostral or transitional milk in the absence of an added stimulus or when cells were stimulated with PMA (0.5 jig/ml). Macrophages obtained from inflammatory exudates or from M. bovis BCG-infected mice are primed to release greater amounts of 02-when stimulated with PMA than are normal, resident cells (6) . In addition, mouse peritoneal macrophages can be similarly primed by exposure in vitro to the bacterial product LPS or to the synthetic glycopeptide MDP (4, 19, 24) . When human milk macrophages were incubated overnight with LPS (10 ng/ml), the cells showed significant spreading, with formation of one or more pseudopods (Fig. 3) , a characteristic associated with activation of macrophages (4, 9, 19) . These cells also twofold increase in PMA-stimulated O2-release at 24 and 48 h in cultures (Fig. 4) . Although mouse peritoneal macrophages can be primed for greater O2 release when preincubated with MDP at 10 p,g/ml (19) , when human breast milk macrophages were incubated with MDP at this concentration, there was no increase in O2 generation (Fig. 4) . When higher concentrations of MDP, up to 100 ,ug/ml, were cultured with human milk macrophages overnight (Fig. 5) , a slight, though insignificant, increase in O2 release was observed (P = 0.1, Student's t test). B30-MDP and L18-MDP, which contain long-chain fatty acids attached to muramic acid, were tested because lipophilic derivatives of MDP have been shown to be more active than MDP in priming mouse macrophages to release O2- (17) . (10 ,ug/ml) gave a slight, but insignificant, increase in 02 (Fig. 5) . In contrast, L18-MDP, which has a greater protective activity against sepsis in mice than does MDP (10), primed milk macrophages to produce twice as much O2-as untreated cells (P < 0.01, Student's t test).
We compared the capacity of adherent milk macrophages cultured overnight with MDP (100 ,ug/ml), B30-MDP (10 ,ug/ml), L18-MDP (10 ,ug/ml), or medium alone to ingest and kill C. albicans in four experiments. Under the conditions used, phagocytosis of candidas was rapid and effective, with 99% of the fungi being ingested by 60 min after addition to adherent macrophages. Each of the four groups of milk macrophages killed approximately 16% of the initial candida inoculum at both 1.5 and 3 h of incubation. (This extent of candida killing approximates that achieved by mouse peritoneal macrophages [24] .) Thus, the enhanced release of O2 by macrophages treated with L18-MDP was not associated with enhanced candidacidal activity. Freshly isolated blood monocytes of lactating women killed 27 + 12% (mean + standard error of the mean; n, 4) of an initial candida inoculum, a result similar to that with control monocytes (30 + 10%; n, 20). Control monocytes cultured for 7 days (monocyte-derived macrophages) killed less of an initial candida inoculum (20 + 7%; n, 5) than when freshly isolated, and the extent of killing approximated that of milk macrophages.
DISCUSSION
We found that human breast milk macrophages undergo a vigorous oxidative metabolic response after stimulation. This oxidative response was equivalent in cells from colostrum and milk, and was as vigorous as the oxidative response in blood monocytes obtained concurrently from the same individual.
Our data indicate that human milk macrophages, like human blood monocytes (18) or rodent peritoneal macrophages (8, 19) , have the capacity to be primed by exposure to bacterial products for a greater release of O2-during stimulation. We have previously shown that human peritoneal 800 r Although release of O2 was increased by exposure of macrophages to L18-MDP, killing of C. albicans was not enhanced by such exposure. We have previously shown that injection of MDP into mice primes their macrophages for a fivefold greater oxidative response and for clearly enhanced candidacidal activity (4) and that in vitro culture of mouse peritoneal macrophages with MDP enhances their oxidative response (19) . We have also reported that killing of C. albicans by mouse macrophages depends at least in part on oxygen metabolites (24) . Thus, it is hot clear why L18-MDP did not increase milk macrophage candidacidal activity. Oxidative metabolism measured by the chemiluminescence response of milk cells has been shown to be negligible, and the possibility was raised that quenching was secondary to intracellular fat (5). Because PMA-stimulated O2 is measured extracellularly and because the enhancement was only twofold, it is possible that the high intracellular fat accumulation in the milk macrophages scavenged any additional metabolites induced by the MDP. Perhaps related to our findings is the observation that milk macrophages, in contrast to blood monocytes, did not show augmentation of tumoricidal activity when exposed to lymphokines (1) . The capacities of macrophages to secrete oxygen metabolites and to kill microorganisms have been closely correlated for several intracellular pathogens (4, 14, 24, 26) ; however, oxidatively deficient human macrophages and fibroblasts can also successfully inhibit the intracellular replication of Toxoplasma gondii and Chlamydia psittaci (13) , demonstrating that killing involves more than generation of oxygen radicals. All types of immunologically active inflammatory cells pass from the human lactating mammary gland into colostrum and milk. After an initial rapid decline of cellular components during the first five days postpartum, the cellular content of breast milk remains relatively constant for at least two months (21) . The milk macrophage, the most numerous of the cells of breast milk, may be responsible, at least in part, for the protection afforded by breast milk against necrotizing enterocolitis in animals (20) . Reported functional capabilities of the human milk macrophage include release of lysozyme, lactoferrin, and PGE2 (2), synthesis of C3 (12) , secretion of epithelial cell growth-stimulatory factor (3), and accessory function in lymphocyte transformation (22) . We demonstrated the following further functional activities of these phagocytic cells: vigorous oxidative response when stimulated with the surface active agent PMA and phagocytosis and killing of C. albicans. LITERATURE CITED
